Anupam Rasayan India Ltd Stock

Stocks

ANURAS

INE930P01018

Specialty Chemicals

Market Closed - 10:05:07 28/10/26 pm AEDT 5-day change 1st Jan Change
1,151.40 INR +1.93% Intraday chart for Anupam Rasayan India Ltd +4.36% -12.70%

Valuation: Anupam Rasayan India Ltd

Market Cap 131B 1.38B 1.23B 1.14B 1.03B 1.93B 1.96B 13.65B 5.44B 68.59B 5.16B 5.06B 218B P/E 2027 *
45.2x
P/E 2028 * 28.9x
Enterprise Value 147B 1.55B 1.39B 1.28B 1.16B 2.17B 2.2B 15.33B 6.11B 77.04B 5.8B 5.68B 245B EV / Sales 2027 *
4.31x
EV / Sales 2028 * 3.31x
Free-Float
16.15%
Yield 2027 *
0.18%
Yield 2028 * 0.29%
29/10 Anupam Rasayan India Ltd Declares Final Dividend for the Financial Year Ended March 31, 2026 CI
28/09 Anupam Rasayan India Ltd completed the acquisition of an additional 43.30% stake in Bliss GVS Pharma Limited from Shruti Vishal Rao, Vibha Gagan Sharma, Narsimha Shibroor Kamath, Gautam Rasiklal Ashra, Arjun Gautam Ashra and Gulbarga Trading and Investment Private Limited. CI
20/09 Anupam Rasayan India Limited Approves Issuance Of INR 1,600 Million Secured Rated Unlisted Redeemable Non-Convertible Debentures On Private Placement Basis CI
09/09 Tanfac Industries Limited announced that it has received INR 994.098627 million in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
08/09 Anupam Rasayan India Ltd Appoints Hetvi Vyas, as Deputy Chief Financial Officer and Key Managerial Personnel CI
06/09 Anupam Rasayan India Limited Secures Chemical Supply Contract With Major Speciality Metal Manufacturer CI
15/08 Anupam Rasayan India Ltd, Q1 2027 Earnings Call, Aug 14, 2026
15/08 Anupam Rasayan India Ltd Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
14/08 Anupam Rasayan India Limited Announces Appointment of Ravi Desai to Chief Operating Officer, Effective August 14, 2026 CI
10/08 Anupam Rasayan India Ltd completed the acquisition of 0.001% stake in Bliss GVS Pharma Limited for INR 0.5 million. CI
17/07 Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million. CI
15/07 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
06/07 Tanfac Industries Limited announced that it expects to receive INR 1.734873 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
1 day+1.93%
1 week+4.36%
Current month-2.51%
1 month-3.01%
3 months-5.50%
6 months-12.11%
Current year-12.70%
1 week 1,077.5
Extreme 1077.5
1,160
1 month 1,067.8
Extreme 1067.8
1,189.8
Current year 1,067.8
Extreme 1067.8
1,415
1 year 1,053.6
Extreme 1053.6
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 51 23/04/2013
Director/Board Member 52 01/01/1992
Chairman 77 31/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.93%+4.36%+5.45%+35.17% 1.35B
+0.39%+1.50%+8.99%+85.73% 81.65B
-0.76%-1.21%+14.68%+29.35% 43.93B
+0.54%-5.12%+11.13%-17.70% 33.93B
+0.03%-0.21%+9.72%+15.79% 33.24B
-0.81%-0.30%+18.73%+51.58% 32.58B
+0.46%+1.59%-1.93%+27.71% 26.14B
-0.65%-5.64%+50.49%+38.52% 24B
+0.73%+3.38%-43.56%-35.93% 18.59B
-2.26%+0.86%+31.83%+15.37% 17.22B
Average -0.04%+0.17%+10.55%+24.56% 31.26B
Weighted average by Cap. -0.11%+0.06%+11.51%+35.78%

Financials

2027 *2028 *
Net sales 34.12B 358M 321M 297M 269M 503M 509M 3.55B 1.42B 17.86B 1.34B 1.32B 56.68B 43.88B 461M 413M 382M 346M 647M 655M 4.57B 1.82B 22.96B 1.73B 1.69B 72.9B
Net income 2.87B 30.09M 26.99M 24.96M 22.6M 42.23M 42.74M 298M 119M 1.5B 113M 111M 4.76B 4.48B 47M 42.17M 38.99M 35.31M 65.97M 66.76M 466M 186M 2.34B 176M 173M 7.44B
Net Debt 16.14B 169M 152M 141M 127M 238M 241M 1.68B 669M 8.44B 636M 622M 26.8B 14.27B 150M 134M 124M 113M 210M 213M 1.49B 592M 7.47B 562M 551M 23.71B
Projected Income Statement - Annual - Anupam Rasayan India Ltd
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Limited is an India-based company engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science-related Specialty Chemicals and Performance Materials. The Life Science-related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, fungicides, and herbicides, among others. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Performance Materials segment includes polymer and electronic chemicals. It manufactures specialty monomers, ionomer and oligomers, including materials with applications in defense, and others.
Employees
2,501
Date Price Change Volume
28/10/26 INR 1,151.40 +1.93% 288,831
27/10/26 INR 1,129.60 +0.45% 300,897
26/10/26 INR 1,124.50 +2.08% 406,524
23/10/26 INR 1,101.60 -0.61% 674,130
22/10/26 INR 1,108.40 +0.46% 420,915
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Anupam Rasayan India Ltd
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,151.40INR
Average target price
1,279.17INR
Spread / Average Target
+11.10%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Anupam Rasayan India Ltd
  1. Stock Market
  2. Stocks
  3. ANURAS Stock